Anagenex operates at the intersection of machine learning and biochemical research, employing advanced technologies like DNA Encoded Libraries (DELs) and Affinity Selected Mass Spectrometry (ASMS) to enhance drug discovery processes. By leveraging large datasets and sophisticated machine learning models, Anagenex works to identify innovative molecules that address complex challenges in medicine, aiming to deliver both first-in-class and best-in-class treatments. The company fosters a collaborative environment where experts in biology, chemistry, and machine learning converge to drive forward the mission of designing new medicines. With a strong emphasis on autonomy and mutual trust, Anagenex nurtures flexibility in the workplace, while also valuing diversity and inclusivity within its teams, ensuring that a variety of perspectives contribute to the company’s success.